一分钟看懂
这是一项关于结直肠癌的不适用研究，登记的药物或干预包括Zhen-Qi-Jie-Du Granules II；Zhen-Qi-Jie-Du Granules I，当前状态为尚未开始招募。登记地点显示中国南京有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Zhen-Qi-Jie-Du Granules II；Zhen-Qi-Jie-Du Granules I · 不适用
登记条件中文摘要
年龄范围：18岁至80岁
登记的基本范围为不限性别，年龄18岁至80岁；以下仅摘录8项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Jiangsu Province Hospital of Chinese Medicine · 南京
入选条件原文摘录
以下为摘录，请打开原始登记查看完整入排标准。
- Subjects meeting all of the following criteria will be eligible to participate in this study:
- 1. Patients with colorectal cancer who have a confirmed pathological diagnosis meeting the diagnostic criteria for the disease; patients with stage IV (MSS) colorectal cancer who are not candidates for curative surgery or who have a confirmed recurrence or metastasis post-surgery and are therefore ineligible for surgical treatment; and patients with at least one measurable lesion assessable according to RECIST 1.1 criteria.
- 2. Have not received prior systemic therapy for metastatic disease (enrolment in the first-line sub-arm); have failed prior first-line treatment or discontinued treatment due to intolerable toxicity (enrolment in the second-line sub-arm); have failed prior second-line treatment or discontinued treatment due to intolerable toxicity (enrolment in the third-line sub-arm).
- 3. Traditional Chinese Medicine (TCM) diagnosis consistent with TCM criteria for colorectal cancer (deficiency of both spleen and kidney, with internal obstruction by stasis and toxins).
- 4. Expected survival of 3 months or more.
- 5. Able to swallow, retain and absorb oral medication
- 6. Aged 18-80 years; both men and women are eligible.
- 7. ECOG performance status score of 0-1. Understand the details of this study, voluntarily agree to participate, and sign the informed consent form.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07854405；登记信息更新于 2026-10-02；本站同步于 2026-10-08，中国中心当前名额未经人工确认。